Search

everythinglearnresearchcommunity

for

Search:↓

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

Dermoscopy effectively diagnoses and evaluates female hair loss treatment.

Cosmerna ARI effectively reduces hair loss and increases hair density in Europeans with androgenetic alopecia.

The treatment effectively promotes hair growth and is well-tolerated.

Low-energy fractional CO2 laser therapy significantly improves hair regrowth in women with female-pattern hair loss.

Recognizing trichoscopic features is crucial for diagnosing various hair loss conditions.

Stem cell therapy from hair follicles effectively treats advanced hair loss with minimal side effects.

Hair diameter diversity could improve androgenetic alopecia assessment and treatment planning.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Hair density and thickness decrease in specific scalp areas in people with androgenetic alopecia.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

The hHa7 gene is regulated by androgens in certain body hair, not scalp hair.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

Triangular temporal alopecia is a benign hair loss pattern best diagnosed with dermoscopy, with limited treatment options like surgery and hair transplantation.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Eosinophilic infiltrate is not a reliable indicator for diagnosing chronic alopecia areata.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.

Male pattern baldness involves three mechanisms and finasteride can help reverse it.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

The device effectively and safely increased hair growth in people with Androgenetic Alopecia.

Using adipose-derived stem cell media with minoxidil may help regrow hair in men with hair loss.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.